Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

计划入组 16 人 · 首次发布于 2017 年 5 月 12 日

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

计划入组 10 人 · 首次发布于 2019 年 12 月 3 日

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

计划入组 20 人 · 首次发布于 2019 年 3 月 19 日

B cell malignancies(Orna)

CD59 inhibitors (B-cell malignancies)

CAR T-cell therapy (B-cell malignancies)

AB&B BIO-TECH-B

Gamida Cell

Israel

GAMIDA CELL INC.

United States

BTK Degraders Show Promise in Pretreated B-Cell Malignancies

Emerging BTK Degraders Show Promise in Treating Resistant B-Cell Malignancies

CAR-T Therapies AT-19 and XYF-19 Show Promise in Treating B-Cell Lymphomas